Tiny bubbles, big ambition: Researchers have developed ultra-simple, biocompatible microrobots that can autonomously navigate the body, home in on tumors, and release cancer drugs on demand. Powered by enzymes and guided by the tumor’s own chemical signals, the so-called “bubble bots” mark a major step toward smart, clinically viable drug delivery systems.
Read on